Search results
Results from the WOW.Com Content Network
In 2012 the Merck Index was licensed to the Royal Society of Chemistry. [3] An online version of The Merck Index, including historic records and new updates not in the print edition, [1] is commonly available through research libraries. It also includes an appendix with monographs on organic named reactions. The 15th edition was published in ...
The Merck Manual—Home Health Handbook is a consumer edition, introduced in 1997. An updated third edition was released in 2009. An updated third edition was released in 2009. The Merck Manual of Patient Symptoms was a small printed reference summary of symptoms intended for medical students , physician assistants , and the like.
The first edition of The Merck Manual was published in 1899 by Merck & Co., Inc. for physicians and pharmacists and was titled Merck's Manual of the Materia Medica. [6] [7] The 192 page book which sold for US $1.00, was divided into three sections, Part I ("Materia Medica") was an alphabetical listing of all known compounds thought to be of therapeutic value with uses and doses; Part II ...
Merck Index: Chemistry, biology, pharmacology: Also available in print. Subscription Formerly produced by Merck & Co., [100] now available from the Royal Society of Chemistry [101] Meteorological and Geoastrophysical Abstracts: Meteorology, astrophysics, geology: Subscription Produced by the American Meteorological Society. Available from ...
Title of the monograph. Copy from the Merck Index Online page, e.g. D-Ribose; defaults to {{PAGENAMEBASE}} date Copy the Last Revised: date from the Merck Index Online page access-date Date you accessed the page on Merck Index Online
The Merck Veterinary Manual was first published in 1955. [1] It was based on the Merck Manual of Diagnosis and Therapy , which was first published in 1899 as a reference for physicians. [ 1 ] The first edition of the Veterinary Manual included contributions from over 200 authors, with 389 chapters divided into sections on public health ...
Merck's new forecast includes a $0.26 per share charge for its $680 million acquisition of cancer drug developer Harpoon Therapeutics, which closed in the first quarter of 2024, the company said.
The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals (11th ed.), Merck, 1989, ISBN 091191028X Template documentation [ view ] [ edit ] [ history ] [ purge ] Usage